[Pancreatic cancer. Etiological and clinical considerations on 140 cases].

L. Gullo,M. Ventrucci,P. Costa,L. Procaccio,V. Nesticò,R. Ripani

Abstract:

What problem does this paper attempt to address?

Solid lipid nanocarriers as alternative drug delivery system for improved oral delivery of drugs

A. Ramesh,G. Thirupathi,Samanthula Kumara Swamy

DOI: https://doi.org/10.22270/JDDT.V10I6-S.4410

2020-12-15

Journal of Drug Delivery and Therapeutics

Abstract:Oral bioavailability of drugs is mainly limited due to the poor aqueous solubility, enhanced chemical degradation, reduced permeation and/or first pass metabolism. Various novel delivery systems are developed for improved oral bioavailability of these drugs such as modified orals, buccal, transdermal and osmotic delivery systems. Colloidal carrier systems such as nanoparticles, lipid nanoparticles, nanoemulsions, microspheres, liposomes, resealed erythrocytes and transfersomes were also developed to enhance the oral delivery. Among these, solid lipid nanocarriers (SLNs) also gain much attention on the enhancement of oral bioavailability. SLNs are submicron sized nanoparticles and composed of solid lipid, surfactants and cosurfactants. The enhanced oral bioavailability of poorly soluble drugs from SLNs might be due to the reduced particle size, bypassed presystemic metabolism, and enhanced gastric mucosa permeability. Vast literature is available for the advantages, limitations, preparation methods, evaluation parameters and application of SLNs in different routes. This review mainly focused on list of drugs developed as SLNs and considered as an alternative approach to enhance the oral bioavailability based on pharmacokinetic as well as pharmacodyanmic parameters was discussed. Keywords: Oral bioavailability, solubility, first-pass metabolism, solid lipid nanoparticles, pharmacokinetics, pharmacodynamics.

Chemistry,Medicine,Materials Science
Predictive factors of sustained sinus rhythm and recurrent atrial fibrillation after a radiofrequency modified Maze procedure.

W. Beukema,H. Sie,A. R. Misier,P. Delnoy,H. Wellens,A. Elvan

DOI: https://doi.org/10.1016/j.ejcts.2008.07.026

IF: 4.534

2008-10-01

European Journal of Cardio-Thoracic Surgery

Abstract:
A Review on Polymer and Lipid-Based Nanocarriers and Its Application to Nano-Pharmaceutical and Food-Based Systems

Hongyun Lu,Shengliang Zhang,Jinling Wang,Qihe Chen

DOI: https://doi.org/10.3389/fnut.2021.783831

IF: 5

2021-01-01

Frontiers in Nutrition

Abstract:Recently, owing to well-controlled release, enhanced distribution and increased permeability, nanocarriers used for alternative drug and food-delivery strategies have received increasingly attentions. Nanocarriers have attracted a large amount of interest as potential carriers of various bioactive molecules for multiple applications. Drug and food-based delivery via polymeric-based nanocarriers and lipid-based nanocarriers has been widely investigated. Nanocarriers, especially liposomes, are more and more widely used in the area of novel nano-pharmaceutical or food-based design. Herein, we aimed to discuss the recent advancement of different surface-engineered nanocarriers type, along with cutting-edge applications for food and nanomedicine and highlight the alternative of phytochemical as nanocarrier. Additionally, safety concern of nanocarriers was also highlighted.
Recent Advances in Lipid Nanoparticle Formulations with Solid Matrix for Oral Drug Delivery

Surajit Das,Anumita Chaudhury

DOI: https://doi.org/10.1208/s12249-010-9563-0

IF: 3.3

2010-12-21

AAPS PharmSciTech

Abstract:Lipid nanoparticles based on solid matrix have emerged as potential drug carriers to improve gastrointestinal (GI) absorption and oral bioavailability of several drugs, especially lipophilic compounds. These formulations may also be used for sustained drug release. Solid lipid nanoparticle (SLN) and the newer generation lipid nanoparticle, nanostructured lipid carrier (NLC), have been studied for their capability as oral drug carriers. Biodegradable, biocompatible, and physiological lipids are generally used to prepare these nanoparticles. Hence, toxicity problems related with the polymeric nanoparticles can be minimized. Furthermore, stability of the formulations might increase than other liquid nano-carriers due to the solid matrix of these lipid nanoparticles. These nanoparticles can be produced by different formulation techniques. Scaling up of the production process from lab scale to industrial scale can be easily achieved. Reasonably high drug encapsulation efficiency of the nanoparticles was documented. Oral absorption and bioavailability of several drugs were improved after oral administration of the drug-loaded SLNs or NLCs. In this review, pros and cons, different formulation and characterization techniques, drug incorporation models, GI absorption and oral bioavailability enhancement mechanisms, stability and storage condition of the formulations, and recent advances in oral delivery of the lipid nanoparticles based on solid matrix will be discussed.

pharmacology & pharmacy
Current applications of solid lipid nanoparticles and nanostructured lipid carriers as vehicles in oral delivery systems for antioxidant nutraceuticals: A review

Maxius Gunawan,Veerakiet Boonkanokwong

DOI: https://doi.org/10.1016/j.colsurfb.2023.113608

Abstract:Antioxidant nutraceuticals can be found in several dietary sources and have been utilized for various medical benefits including health promotion, disease prevention, and support for treatment of acute and/or chronic diseases. Nonetheless, there are some limitations in delivering antioxidants via oral administration such as low solubility and permeability, pH and enzyme degradation, and instability of the compounds along the gastrointestinal tract leading to low bioavailability. In order to tackle these challenges, the utilization of lipid nanoparticles has numerous advantages to the escalating delivery system of antioxidants in nutraceuticals across the gastrointestinal tract barrier. Nowadays, several types of lipid nanoparticles can be used in antioxidant nutraceutical delivery systems through the oral route, namely solid lipid nanoparticles and nanostructured lipid carriers. This review article aims to provide notable information on the importance and applications of lipid nanoparticles in antioxidant delivery systems from nutraceuticals by an oral route. The mechanism in enhancing antioxidant compound transport across the gastrointestinal tract can occur by elevating loading capacity, improving chemical and physical stability, and increasing its bioavailability. To date, lipid nanoparticle vehicles have been developed to improve the delivery of antioxidant compounds to enhance bioavailability via oral routes. Lipid nanoparticles have remarkable benefits in delivering antioxidant nutraceuticals via oral administration. Hence, scale-up and commercialization of antioxidant nutraceutical-loaded lipid nanoparticles have been a potential technology in recent years. Subsequently, several vegetable and natural oils with antioxidant activity can also be utilized for nanoparticle formulation lipid components to increase nutraceuticals' antioxidant properties and bioavailability.
A surgeon operates on his son: wisdom or hubris?

K. Oberheu,James W. Jones,R. Sade

DOI: https://doi.org/10.1016/J.ATHORACSUR.2007.06.033

2007-09-01

Abstract:
Lipid-Based Nanoparticles in Delivering Bioactive Compounds for Improving Therapeutic Efficacy

Priya Patel,Kevinkumar Garala,Sudarshan Singh,Bhupendra G. Prajapati,Chuda Chittasupho

DOI: https://doi.org/10.3390/ph17030329

IF: 4.6

2024-03-02

Pharmaceuticals

Abstract:In recent years, due to their distinctive and adaptable therapeutic effects, many natural bioactive compounds have been commonly used to treat diseases. Their limited solubility, low bioavailability, inadequate gastrointestinal tract stability, high metabolic rate, and shorter duration of action limited their pharmaceutical applications. However, those can be improved using nanotechnology to create various drug delivery systems, including lipid-based nanoparticles, to adjust the compounds' physicochemical properties and pharmacokinetic profile. Because of the enormous technical advancements made in the fundamental sciences and the physical and chemical manipulation of individual atoms and molecules, the subject of nanotechnology has experienced revolutionary growth. By fabricating certain functionalized particles, nanotechnology opens an innovative horizon in research and development for overcoming restrictions, including traditional medication administration systems. Nanotechnology-driven bioactive compounds are certain to have a high impact and clinical value for current and future uses. Lipid-based nanotechnologies were shown to deliver a range of naturally occurring bioactive compounds with decent entrapment potential and stability, a successfully controlled release, increased bioavailability, and intriguing therapeutic activity. This review outlines bioactive compounds such as paclitaxel, curcumin, rhodomyrtone, quercetin, kaempferol, resveratrol, epigallocatechin-3-gallate, silymarin, and oridonin, fortified within either a natural or synthetic lipid-based drug delivery system based on nanotechnology and their evaluation and clinical considerations.

pharmacology & pharmacy,chemistry, medicinal
Solid Lipid Nanoparticles (SLNs): Advancements in Modification Strategies Toward Drug Delivery Vehicle

Galal Mohsen Hussein Al-Sayadi,Abhishek Verma,Yash Choudhary,Pallavi Sandal,Preeti Patel,Dilpreet Singh,Ghanshyam Das Gupta,Balak Das Kurmi

DOI: https://doi.org/10.2174/2211738511666221026163303

Abstract:Solid lipid nanoparticles are at the cornerstone of the swiftly growing area of medical nanotechnology, having several potential functions in drug delivery, research, clinical care, and a variety of other fields. They provide the opportunity of developing novel therapies due to their unique properties, such as small particle size and being prepared from physiological biodegradable lipids. The loading of bioactive molecules into nanocarriers is a novel drug delivery prototype employed for various drug targeting levels. Hence, SLNs hold a great promise for achieving the aim of targeted and controlled drug delivery. For this reason, they have attracted the extensive attention of scientists and researchers. This review is based on recent studies and research, and here we present advantages, disadvantages, and preparation methods, several advanced modifications, targeting strategies, and recent applications of solid lipid nanocarriers in drug delivery systems.
A REVIEW ON SOLID LIPID NANOPARTICLES

RIDHIMA RAJ,ARINDAM KOLAY,UJWAL HAVELIKAR

DOI: https://doi.org/10.22159/ijcpr.2023v15i5.3051

2023-09-15

International Journal of Current Pharmaceutical Research

Abstract:Over the past decade, there has been a lot of research on solid lipid nanoparticles (SLNs), also known as lipid carriers. As a new lipid-based drug delivery technology for the topical applications of numerous medicinal drugs, solid lipid nanoparticles (SLNs) have demonstrated promise. SLNs have undergone considerable research on every continent and have become effective nano-sized medication carriers. There is no doubt that nano-formulations are extremely valuable tools for drug delivery applications; the current challenge is how to optimize them to ensure that they are safe, effective and scalable, so that they can be manufactured at an industrial level and advance to clinical use. In this context, lipid nanoparticles have gained ground, since they are generally regarded as non-toxic, biocompatible and easy-to-produce formulations. However, the processes governing SLN cellular uptake and absorption by topical application, as well as the mechanism of SLN drug release, are still unclear and need further research. To make SLNs easier to apply and to improve cutaneous and transdermal administration, it is also crucial to choose the right dose form and formulation base. Additional difficulties that could prevent the clinical translation of SLNs include scaling up and regulatory authorization. Therefore, the main focus of this research is on the various pathways that SLNs use to enter cells and penetrate skin. The physicochemical characteristics of SLNs are then thoroughly discussed, including numerous formulation and dosage form parameters that may affect SLN absorption via the skin. The translational status in relation to scale-up and regulatory issues are also covered in the discussion. Researchers interested in topical uses of SLNs for the effective delivery of medications and cosmetics will find this review to be helpful.
Preventing type 2 diabetes: making the evidence work for migrant Indian populations.

T. Yates,K. Khunti,M. Davies

2009-11-01

The Indian Journal of Medical Research

Abstract:Type 2 diabetes mellitus is a chronic and debilitating disease characterized by an inability to adequately regulate blood glucose levels. The symptoms of type 2 diabetes are associated with a reduced quality of life in the short term, whilst in the longer term the disease may lead to serious complications such as cardiovascular disease, blindness, renal failure and amputation1. The prevalence of type 2 diabetes is currently estimated to be around 6 per cent by the International Diabetes Federation, and growing2 as such it is now thought to be the fifth leading cause of mortality globally3. Data from India and elsewhere have shown that 50 per cent or more of individuals with type 2 diabetes die of cardiovascular disease and that life expectancy is substantially reduced by up to 9 years in those diagnosed at age 40 yr or more, with greater reductions in life expectancy occurring in those diagnosed at a younger age4,5. The enormous public health burden of type 2 diabetes and its associated co-morbidities are a relatively recent phenomenon; indeed type 2 diabetes was a relatively rare condition until the latter half of the 20th century. This rise was closely mirrored by a dramatic increase in industrialized environments where energy dense foods are plentiful and the link between physical activity and food procurement has been broken. Over the past few decades India has provided a good case study of this phenomenon with the rapid expansion of, and migration to, urban centres. India now heads the international league table for the highest number of subjects with type 2 diabetes, a position it is expected to maintain into the future with 80 million individuals estimated to have type 2 diabetes by 20302,6. The Indian genotype and/or culture seems to be particularly susceptible to type 2 diabetes when exposed to industrialized environments7,8. For example, the prevalence of type 2 diabetes in urban areas has been shown to be up to 5 times higher than rural settings9. Data from the Indian Diaspora also tell a revealing story. In the United Kingdom (UK), where Indian migrants and their families now form the largest ethnic minority group, the prevalence of type 2 diabetes has been estimated to be 4 6 times higher than that in the general population10. The reasons for this are incompletely understood, despite various hypotheses10. However, clearly lifestyle factors related to migration are a major causal factor. For example, data from industrialized countries have shown that migrant south Asian communities undertake around half the amount of daily physical activity and have higher levels of central obesity compared to the host white European population10,11. Given these startling figures, strategies and policies aimed at preventing type 2 diabetes in migrant Indian populations are essential and constitute a growing public health priority for India and other countries with large Indian populations.
Recent Advances in the Preparation, Properties, and Applications of Solid Lipid Nanoparticles in Drug Delivery

Ujjwal Kumar Biswas,Anindya Bose,Ankita Parmanik

DOI: https://doi.org/10.2174/0122117385333634240911075833

2024-09-19

Abstract:Solid lipid nanoparticles (SLNs) are one of the extensively utilized nanocarriers in the pharmaceutical field due to their biocompatibility and biodegradability. These features of the carrier system have fuelled its use as the drug delivery system since the last three decades. This review presents different SLN preparation techniques, such as high shear homogenization, hot homogenization, cold homogenization, microemulsion-based technique, etc. The physicochemical nature of SLNs, comprising drug loading, drug release, particle size, zeta potential, stability, cytotoxicity, and cellular uptake, has been concisely discussed. The article also explains why SLNs are preferred to develop drug delivery systems in several pharmaceutical preparations. The key ingredients like lipid, surfactant/ stabilizer accompanied by co-surfactant, cryoprotectant, or charge modifiers used to fabricate SLNs are also briefly conferred. Here is an elaborate discussion of drugs that are used through various routes by the SLN carrier system and their outcome for utilization of this system. Regulatory aspects, patent aspects, and future prospects of SLN are also discussed here.
Solid Lipid Nanoparticles: Drug Delivery Systems for Enhancing the Bioavailability of Antihypertensives

Neeraj K. Chauhan,Anuj Malik,Paramjeet K. Ratiyen

DOI: https://doi.org/10.25258/ijddt.13.3.46

2023-09-25

International Journal of Drug Delivery Technology

Abstract:The pharmaceutical industry focuses the SLNs as promising drug deliverance methods for improving bioavailability. SLNs are a swiftly budding field of nanotechnology amid plentiful budding applications in medicine and research. Lipid-based nanoparticles possess unique properties due to their small size, allowing novel therapeutics to be developed. The encapsulation of drugs within nano-carriers presents a new paradigm in drug delivery, enabling enhanced targeting at secondary and tertiary levels. Consequently, SLNs have garnered significant attention from researchers for their site-specific drug delivery. This review enlightens on the responsibilities of SLN for improving the pharmacokinetics of poorly soluble antihypertensive drugs. Profound investigations confirmed SLNs have latent to transfigure antihypertensives through enhanced oral delivery.
Solid Lipid Nanoparticles: A Potential Option for Enhancing Oral Bioavailability of Highly Soluble and Poorly Permeable (BCS Class III) Drugs

Sri Rekha M,Sangeetha S,Seetha Devi A

DOI: https://doi.org/10.2174/1567201819666220418100410

Abstract:Oral administration of drug is the most preferred one among the other routes for the majority of clinical applications. As compared to the parenteral method of administration, it has potential benefits such as increased patient compliance, fewer problems, and reduced treatment costs. Regardless of these factors, inadequate bioavailability owing to poor solubility or permeability limits the therapeutic effectiveness of orally given drugs. Though most current research focuses on BCS II (drugs with low solubility and high permeability), BCS III (drugs with high solubility and low permeability) also has poor oral bioavailability due to their limited permeability across lipid membranes and is usually administered through the parenteral route. The need for an oral alternative to parenteral administration has prompted a renewed focus on the development of innovative dosage forms that support the absorption of medicines that are poorly permeable through the intestinal epithelium. Because of their unique sizedependent feature in enhancing transmembrane permeability, ability to incorporate both lipophilic and hydrophilic drugs and biocompatible nature of components, the use of nanoparticles for improving drug bioavailability has been a focus of current study in the field of drug delivery in recent years. The lipidbased nanoparticle method presents a potential new avenue for manufacturing BCS Class III medicines with enhanced bioavailability, as poor permeability is the main issue for these agents. This research aims to assess the potential of lipid nanoparticles for improving the oral bioavailability of medicines with permeability-restricted oral absorption, such as pharmaceuticals in Biopharmaceutical Classification System (BCS) class III.
Through and Through Defect on the Helix and Antihelix.

Andrea Willey

DOI: https://doi.org/10.1097/DSS.0000000000000838

2016-09-01

Dermatologic Surgery

Abstract:
Solid lipid nanoparticles; as a promising drug delivery method to get greater bioavailability: A review

Manisha A. Lavate,Sujit T. Karpe,Sidaray N. Biradar,Madanna R. Bhandare

DOI: https://doi.org/10.30574/wjbphs.2023.14.2.0104

2023-05-30

World Journal of Biology Pharmacy and Health Sciences

Abstract:Solid lipid nanoparticles (SLN) are the heart of nanotechnology's tremendous development, with multiple practical benefits in drug delivery and research. Because of their size-dependent properties, solid Lipid nanoparticles can be used to create innovative medicines. Drug conversion into nanoparticles provides a new drug delivery concept that could be used for drug targeting. As a result, solid lipid nanoparticles have great promise reaching the goal of targeted and site-specific drug delivery. The goals, production techniques, advantages, limits are all discussed in this review. Scanning electron microscopy and measurement of particle size and zeta potential, dynamic light scattering are examples of appropriate analytical techniques for SLN characterization. By using novel drug formulation technologies, the drug delivery system focuses on the regulation of in vivo dynamics in order to enhance the efficacy and safety of the included pharmaceuticals. Lipids used in the development of Nano particulate dosage forms, such as fatty acids, triglycerides, vegetable oils, and their derivatives. Solid lipid nanoparticles (SLNs) are a type of lipid drug delivery method that is relatively new. They were created to solve some of the limitations with traditional drug delivery systems, such as low drug encapsulation efficiency and limited bioavailability of Biopharmaceutical Classification Systems (BCS) class II and IV medications. SLNs are made up of physiologically well tolerated substances and melt-emulsified lipids that are solid at room temperature that helps to enhance drug bioavailability ultimately results in better desired therapeutic effect.
Nanostructured lipid carriers: A platform to lipophilic drug for oral bioavailability enhancement

Deepak Patil,Seema Pattewar,Sarvesh Palival,Gargi Patil,Swapnil Sharma

DOI: https://doi.org/10.22270/jddt.v9i3-s.2750

2019-06-15

Journal of Drug Delivery and Therapeutics

Abstract:Lipid based drug delivery system such as Solid lipid nanoparticle (SLN) and Nanostructured lipid carriers (NLC) are among the most promising drug delivery system used in many industries such as food, pharmaceuticals and cosmetics industries. Over the last few years, new constituents of lipids have developed and investigated for enhancement of bioavailability. The present manuscript is an attempt on solving the concerned uncertainty with efficacious peroral administration of hydrophobic drugs through fabricating new lipid formulations, NLC. NLC, the second-generation lipid carrier is usually composed of solid lipids and liquid lipids together in a system. This mixing causes depression in melting point of substrates and converts the mixture into solid form at body temperature and termed as NLC. NLC shows a high drug loading with minimum drug expulsion. The unique advantages of NLC over SLN and Lipid-drug conjugates (LDC) are increased capacity of drug loading, avoidance of drug expulsion. This manuscript gives detailed information on definitions and simple way of production methods, new approaches in formulation of NLC and it also highlights how NLC improves bioavailability of bioactive molecules through peroral route and its future perspective as a pharmaceutical carrier. It also gives idea about the supremacy of NLC over other lipid-based system. Keywords: Bioavailability; Lipids; Lipophilic drugs; Nanostructured lipid carriers; Solid lipid nanoparticle.
Lipid Nanocarriers as an Alternative for the Delivery of Bioactive Compounds Beneficial to Health

Camila da Costa de Quadros,Alan Carvalho de Sousa Araujo,Juliana Machado Latorres,Mariano Michelon,Myriam de las Mercedes Salas-Mellado

DOI: https://doi.org/10.2174/1573407219666230306142421

2023-03-06

Current Bioactive Compounds

Abstract:Abstract: Bioactive compounds derived from food or plants have become a natural source with the potential for producing functional, nutraceutical, and pharmaceutical foods due to their biological functions and beneficial health effects. However, to perform such physiological processes, these compounds need to be absorbed through the gastrointestinal tract. Among the existing technologies, nanoencapsulation increases physical stability, protection, and the contact surface, facilitating the solubility and bioavailability of such compounds. In this type of encapsulation, lipid nanocarriers are promising carriers due to their lipid structure and containing hydrophilic surfactant, capable of facilitating the intestinal absorption of active compounds. However, in food or drugs, one of the significant challenges for applying bioactive compounds on a nanoscale is the lack of in vivo studies that establish safety limits for cytotoxicity. This review covered recent studies on the encapsulation of natural bioactive compounds in different types of lipid nanocarriers. In addition to methods for obtaining and characterizing nanocarriers, bioactivities with beneficial potential for human health, such as antioxidant, antimicrobial, antihypertensive, antidiabetic, and neuroprotective, are mentioned. The manuscript deals with the bioaccessibility of active compounds, new perspectives, and challenges for applying lipid nanocarriers.
Absorption, disposition and pharmacokinetics of solid lipid nanoparticles.

Jianping Qi,Yi Lu,Wei Wu

DOI: https://doi.org/10.2174/138920012800166526

2012-01-01

Current Drug Metabolism

Abstract:Solid lipid nanoparticles (SLNs) are primarily composed of solid lipids, which thus impart to them some of the fundamental properties of these lipids, including biocompatibility, biodegradability and low-toxicity. SLNs represent a unique class of colloidal drug delivery systems that possess the advantages of both the "soft" drug carriers such as emulsions and liposomes and polymeric nanoparticles. In this review, we will provide an overview on the absorption, disposition and pharmacokinetics of SLNs. The lipidic nature, as well as the relatively small particle size, of SLNs ensures sufficient affinity with the biomembranes, and results in improved absorption by either of the oral, transdermal, pulmonary, nasal, ocular, rectal or buccal route. One special aspect of oral SLNs is the enhanced lymphatic absorption by either the chylomicron-association pathway or the M cell uptaking pathway. Intravenous SLNs are predominantly uptaken by the liver or spleen following opsonization by the complementary system. Modification of SLN surface with PEGs chains will mask the hydrophobic surface and divert SLNs to non-hepatic and non-splenic organs, while ligand-modification will achieve active targeting to specific tissues or organs. Degradation of SLNs is primarily based on the degradation of the lipids themselves by lipase. Pharmacokinetics reflects the effect of the lipidic vehicles of SLNs on in vivo disposition of the loaded drugs.
Solid Lipid Nanoparticles: Review of the Current Research on Encapsulation and Delivery Systems for Active and Antioxidant Compounds

Edy Subroto,Robi Andoyo,Rossi Indiarto

DOI: https://doi.org/10.3390/antiox12030633

IF: 7.675

2023-03-04

Antioxidants

Abstract:Various active compounds are easily damaged, so they need protection and must be easily absorbed and targeted. This problem can be overcome by encapsulating in the form of solid lipid nanoparticles (SLNs). Initially, SLNs were widely used to encapsulate hydrophobic (non-polar) active compounds because of their matched affinity and interactions. Currently, SLNs are being widely used for the encapsulation of hydrophilic (polar) and semipolar active compounds, but there are challenges, including increasing their entrapment efficiency. This review provides information on current research on SLNs for encapsulation and delivery systems for active and antioxidant compounds, which includes various synthesis methods and applications of SLNs in various fields of utilization. SLNs can be developed starting from the selection of solid lipid matrices, emulsifiers/surfactants, types of active compounds or antioxidants, synthesis methods, and their applications or utilization. The type of lipid used determines crystal formation, control of active compound release, and encapsulation efficiency. Various methods can be used in the SLN fabrication of active compounds and hydrophilic/hydrophobic antioxidants, which have advantages and disadvantages. Fabrication design, which includes the selection of lipid matrices, surfactants, and fabrication methods, determines the characteristics of SLNs. High-shear homogenization combined with ultrasonication is the recommended method and has been widely used because of the ease of preparation and good results. Appropriate fabrication design can produce SLNs with stable active compounds and antioxidants that become suitable encapsulation systems for various applications or uses.

biochemistry & molecular biology,chemistry, medicinal,food science & technology
Biomacromolecule-based nanocarrier strategies to deliver plant-derived bioactive components for cancer treatment: A recent review

Bapi Gorain,Varnita Karmakar,Biswatrish Sarkar,Monika Dwivedi,Janelle Tsui Lyn Leong,Jing Hen Toh,Even Seah,Kang Yi Ling,Kah Yee Chen,Hira Choudhury,Manisha Pandey

DOI: https://doi.org/10.1016/j.ijbiomac.2023.126623

2023-12-31

Abstract:The quest for safe chemotherapy has attracted researchers to explore anticancer potential of herbal medicines. Owing to upsurging evidence of herbal drug's beneficial effects, hopes are restored for augmenting survival rates in cancer patients. However, phytoconstituents confronted severe limitations in terms of poor absorption, low-stability, and low bioavailability. Along with toxicity issues associated with phytoconstituents, quality control and limited regulatory guidance also hinder the prevalence of herbal medicines for cancer therapy. Attempts are underway to exploit nanocarriers to circumvent the limitations of existing and new herbal drugs, where biological macromolecules (e.g., chitosan, hyaluronic acid, etc.) are established highly effective in fabricating nanocarriers and cancer targeting. Among the discussed nanocarriers, liposomes and micelles possess properties to cargo hydro- and lipophilic herbal constituents with surface modification for targeted delivery. Majorly, PEG, transferrin and folate are utilized for surface modification to improve bioavailability, circulation time and targetability. The dendrimer and carbon nanotubes responded in high-loading efficiency of phytoconstituent; whereas, SLN and nanoemulsions are suited carriers for lipophilic extracts. This review emphasized unveiling the latent potential of herbal drugs along with discussing on extended benefits of nanocarriers-based delivery of phytoconstituents for safe cancer therapy owing to enhanced clinical and preclinical outcomes without compromising safety.

[Pancreatic cancer. Etiological and clinical considerations on 140 cases].

Solid lipid nanocarriers as alternative drug delivery system for improved oral delivery of drugs

Predictive factors of sustained sinus rhythm and recurrent atrial fibrillation after a radiofrequency modified Maze procedure.

A Review on Polymer and Lipid-Based Nanocarriers and Its Application to Nano-Pharmaceutical and Food-Based Systems

Recent Advances in Lipid Nanoparticle Formulations with Solid Matrix for Oral Drug Delivery

Current applications of solid lipid nanoparticles and nanostructured lipid carriers as vehicles in oral delivery systems for antioxidant nutraceuticals: A review

A surgeon operates on his son: wisdom or hubris?

Lipid-Based Nanoparticles in Delivering Bioactive Compounds for Improving Therapeutic Efficacy

Solid Lipid Nanoparticles (SLNs): Advancements in Modification Strategies Toward Drug Delivery Vehicle

A REVIEW ON SOLID LIPID NANOPARTICLES

Preventing type 2 diabetes: making the evidence work for migrant Indian populations.

Recent Advances in the Preparation, Properties, and Applications of Solid Lipid Nanoparticles in Drug Delivery

Solid Lipid Nanoparticles: Drug Delivery Systems for Enhancing the Bioavailability of Antihypertensives

Solid Lipid Nanoparticles: A Potential Option for Enhancing Oral Bioavailability of Highly Soluble and Poorly Permeable (BCS Class III) Drugs

Through and Through Defect on the Helix and Antihelix.

Solid lipid nanoparticles; as a promising drug delivery method to get greater bioavailability: A review

Nanostructured lipid carriers: A platform to lipophilic drug for oral bioavailability enhancement

Lipid Nanocarriers as an Alternative for the Delivery of Bioactive Compounds Beneficial to Health

Absorption, disposition and pharmacokinetics of solid lipid nanoparticles.

Solid Lipid Nanoparticles: Review of the Current Research on Encapsulation and Delivery Systems for Active and Antioxidant Compounds

Biomacromolecule-based nanocarrier strategies to deliver plant-derived bioactive components for cancer treatment: A recent review